
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Neil Friedman, COO of Bodimetrics, explains how pharmacists can best leverage the Bodimetrics Performance Monitor technology in their day-to-day practice.
Neil Friedman, COO of Bodimetrics, explains how pharmacists can best leverage the Bodimetrics Performance Monitor technology in their day-to-day practice.
This video was recorded at the NACDS Total Store Expo in August 2015 in Denver, Colorado.






